Global Market Study on Trichomonas Rapid Testing - Feasibly Instrumenting the Early Diagnosis of Trichomoniasis


Trichomonas Rapid Testing  Market
  • Published On : Sep-2019 |
  • Pages : 211 Pages |
  • Format :

Trichomonas Rapid Testing Market: Introduction

The latest market report by PMR on the global trichomonas rapid testing market evaluates opportunities and current market scenarios, and provides insights and updates about corresponding segments involved in the global trichomonas rapid testing market during the forecast period 2019-2029. The global trichomonas rapid testing market report further exhibits the estimated data for 2019, and forecast data up to 2029 in terms of value (US$ millions). In terms of value, the global trichomonas rapid testing market will grow at ~ 4% CAGR over the forecast period. The present study exhibits trends and market dynamics of the trichomonas rapid testing market. It includes North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East & Africa. The report also includes the study of current issues with consumers, and various future opportunities for the trichomonas rapid testing market.

Trichomonas Rapid Testing Market: Report Description

The report explores the global trichomonas rapid testing market for the period 2019–2029. The primary objective of the global trichomonas rapid testing market report is to provide insights of various opportunities in the market that are consistently supporting the transformation of global businesses. It is very important to consider that in an ever-wavering economy, we provide the estimated (Y-o-Y) year-on-year growth rate in addition to the compound annual growth rate (CAGR) for the overall forecast, to better understand the analysis and evaluation of the global trichomonas rapid testing market, and to discover equitable opportunities.

Yet another key feature of this report is the estimation of the global trichomonas rapid testing market and the corresponding revenue forecast carried out in terms of absolute dollar opportunity. This is usually not prioritized while forecasting overall market numbers. Absolute dollar opportunity analysis is very essential in evaluating the degree of opportunity that a provider can observe to execute, as well as to contrast the potential resources from a sales perspective in the global trichomonas rapid testing market.

The global trichomonas rapid testing market report starts with an elaborate executive summary, market definition of various segmentations that are included, and their respective shares in the market. The report further incorporates major macro and micro-economic factors that have an effect on the growth of the trichomonas rapid testing market. The report also highlights various market dynamics, which include the drivers and restraints in the global trichomonas rapid testing market. Current opportunities, as well as on-going trends in the trichomonas rapid testing market are also discussed in this report. The report further underlines the study of present issues with industrial processing, and opportunities for the trichomonas rapid testing market. In order to provide users with a clear view of the global trichomonas rapid testing market, we have exhibited a competitive analysis of the key market players and their strategy for expansion. The competitive dashboard presents a detailed comparison of trichomonas rapid testing kit manufacturers on valuable parameters such as key product offerings, total revenue, key developments, and strategies. The study intensifies the global trichomonas rapid testing market attractiveness analysis by product type, sample type, end user, and region.

To evaluate the overall market size of trichomonas rapid testing, the report considers various fundamental aspects based on secondary research. Furthermore, it emphasizes on quantitative evaluation such as market share by product type, sample type, end user, and region. Other qualitative data from primary respondents, which has been consolidated to arrive at clear and accurate market estimations has been included.

The market size was obtained by taking into consideration the incidence rate of trichomonas infection by country, adoption rate by product type, and average selling price of per kit. The region wise incidence rate data for trichomonas infection is obtained from sources such as WHO, American Sexual Health Associations, research publications, and others. The diagnosed rate and treatment-seeking population has been derived from the incident cases. The market value derived from the modelling approach is then validated with company share analysis, in which the market revenue was divided on the basis of company’s product offerings. The average utilization of trichomonas rapid testing was deducted from the company reports and research publications, and was used to triangulate the process. The forecast presented in the trichomonas rapid testing market report arrives at the total revenue being generated, and expected revenue contribution in the future by the global trichomonas rapid testing market.

Trichomonas Rapid Testing Market: Competition Analysis

Cepheid, Quidel Corporation, Becton, Dickinson and Company (BD), Hologic Inc., Sekisui chemical co. ltd (Sekisui Diagnostics), Creative Diagnostics, Nal Von Minden GmbH, Common Sense Ltd., Jei Daniel Biotech Corp., Nanjing Liming Bio-products Co., Ltd, Koroglu Medical Devices, etc., are the major players involved in the trichomonas rapid testing market.

Trichomonas Rapid Testing Market: Segmentation

The subsequent sections analyze the global trichomonas rapid testing market on the basis of product type, sample type, end user, and region to present a forecast for the period 2019–2029. The market is segmented as follows:

On the basis of product type, the global trichomonas rapid testing market has been segmented as –

  • Cassette Rapid Test Kits
  • Rapid Test Strips
  • Rapid Test Swabs
  • Molecule Based Rapid Test Kits

On the basis of sample type, the global trichomonas rapid testing market has been segmented as

  • Urine
  • Vaginal/Urethra Swab

On the basis of end user, the global trichomonas rapid testing market has been segmented as

  • Hospitals
  • Diagnostic Laboratories
  • Specialty Clinics
  • Others

On the basis of region, the global trichomonas rapid testing market has been segmented as-

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East & Africa

PMR Research Methodology

PMR is committed to providing unbiased market research solutions to its clients. PMR follows a robust methodology for deducing the data that is included in this report. A demand-side approach is followed to estimate the sales of target products, followed by an in-depth supply-side assessment of value generated, key trends, and events over a predefined period. This methodology is based on the use of standard market structures, methods, and definitions that are based on inputs from local sources in over seven regions, i.e. Europe, East Asia, Latin America, Middle East and Africa, North America, Oceania and South Asia, which PMR considers for segmenting the global market. Statistics, characteristics, and variances are collected at a regional level, aggregated at the same level, and then synthesized at a worldwide level to create global market measurements. Our main sources of research include,

  • Primary Research
  • Secondary Research
  • Trade Research
  • Social Media Analysis

Trichomoniasis is the most common curable and non-viral sexually transmitted infection (STI). It is caused by a protozoan parasite called Trichomonas vaginalis. The World Health Organization report evaluates the annual global incidences of trichomonas infection at over 170 million cases. Men typically do not show any symptoms. Women on the other hand, if infected, may show symptoms such as vaginal discharge, genital itching, burning or redness. Traditionally, trichomonas is detected using microscopic detection methods such as wet mount and cell culture, which have low sensitivity and take ample time compared to advanced trichomonas rapid testing methods such as antigen detection and molecular-based techniques, which have high sensitivity and specificity. Based on product type, trichomonas rapid testing is further classified into four categories, which are cassette rapid test kits, rapid test strips, rapid test swabs, and molecule-based trichomonas rapid testing kits.

Once thought to be a minor sexually transmitted infection, Trichomonas vaginalis is now being given more attention due to its evident role in both the acquisition and transmission of HIV infection, and association with adverse and noxious health outcomes, such as preterm birth, low-birth-weight baby, and risk of transmission of infection to the new-born. Doctors recommend use of trichomonas rapid testing kits in pregnant women.trichomonas rapid testing market

Acquisitions and Collaborations to Expand Trichomonas Rapid Testing Businesses in Developing Countries

In countries such as India, China, and South Africa, there is lack of awareness and advancement in the area of STI detection. These countries do not have accessibility to modern trichomonas rapid testing techniques and still utilize old unreliable methods, such as wet mount for testing trichomoniasis. This situation leaves a vast opportunity for trichomonas rapid testing kit manufacturing companies for strategic alliances such as acquisitions and mergers, which could pave the way to expand their businesses in untapped countries. These collaborations help companies to expand their portfolio of trichomonas rapid testing methods and also allow distribution channels of native companies, thus providing growth in the trichomonas rapid testing market. Moreover, changing demographics in emerging nations and favorable government policies to support the expansion by leading manufacturers in these countries are opening opportunities for trichomonas rapid testing kit manufacturers to upsurge their revenue.

Growing Demand for User-Friendly and Cost-Effective Trichomonas Rapid Testing Kits

The demand for trichomonas rapid testing kits, which are easy-to-use, low-cost, and have less turn-around-time has increased in the past few years. To meet such needs of healthcare personnel and patients, manufacturers are developing point-of-care devices, which are available for home as well as professional use. Traditional trichomonas testing method includes usage of wet mount test, however, the sensitivity of such microscopic methods ranges from 36 - 70% only, and the test needs to be performed within 10 minutes of sample collection due to declination in motility of the organism. Development of modern trichomonas rapid testing techniques by leading companies have changed the scenario with trichomonas rapid testing diagnostic methods having sensitivity and specificity rates greater than 90% and turn-around-time reduced to few seconds to three hours maximum. Also, Centers for Disease Control and Prevention recommends use of modern trichomonas rapid testing kits for diagnosis of the infection. Such developments to meet the demand for modern techniques is expected to fuel the market growth of trichomonas rapid testing.

Growth Opportunities for Trichomonas Rapid Testing Market in North America and Europe

North America continues to be a prominent market for trichomonas rapid testing. The region’s burgeoning research & development includes presence of massive biotechnology companies, contract manufacturing bodies, and contract research organizations including research institutes and universities. Moreover, some studies evaluate that trichomonas infection affects more African-American women than white and Hispanic women. The threat of catching trichomoniasis elevates with age and the number of sexual partners over the course of time in African-American women. These factors create a lucrative circumstance for the trichomonas rapid testing market. Europe is expected to be at second position among the leading regional markets of trichomonas rapid testing owing to the growing number of contract research in the region. Besides, increasing sales force is likely to expand the trichomonas rapid testing products reach across these two regions through distribution & collaboration agreements. These opportunities will lead to the market growth of trichomonas rapid testing in these regions.

Minimal to No Symptoms Shown by Trichomonas Infected Person

According to CDC, around 70% - 85% of the people affected with the infection show minimal or no symptoms at all. Moreover, infected men are less likely to show any symptoms as compared to infected women, indicated by some studies. Besides the high prevalence rate of the infection, the disease remains undiagnosed due to the high percentage of asymptomatic patients. These factors are expected to affect the trichomonas rapid testing market in a negative way and could possibly slow down the market growth rate.

Company Profile

  • Sekisui Diagnostics (Sekisui Chemical)
  • Cepheid
  • Quidel Corporation
  • Becton, Dickinson and Company
  • Hologic, Inc.
  • Creative Diagnostics
  • Koroglu Medical Devices
  • Nal Von Minden GmbH
  • Common Sense
  • Jei Daniel Biotech Corp
  • Nanjing Liming Bio-products Co., Ltd

 

Back To Top